{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T14:07:10Z","timestamp":1789913230936,"version":"4.0.1"},"reference-count":53,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2014,7,30]],"date-time":"2014-07-30T00:00:00Z","timestamp":1406678400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0103478","type":"journal-article","created":{"date-parts":[[2014,7,30]],"date-time":"2014-07-30T20:36:27Z","timestamp":1406752587000},"page":"e103478","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":33,"title":["Interferon Regulatory Factor-5 Deficiency Ameliorates Disease Severity in the MRL\/lpr Mouse Model of Lupus in the Absence of a Mutation in DOCK2"],"prefix":"10.1371","volume":"9","author":[{"given":"Kei","family":"Yasuda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda A.","family":"Watkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guneet S.","family":"Kochar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella E.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bari","family":"Laskow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Richez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramon G.","family":"Bonegio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian R.","family":"Rifkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,7,30]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1038\/nm.2752","article-title":"Taming lupus-a new understanding of pathogenesis is leading to clinical advances","volume":"18","author":"Z Liu","year":"2012","journal-title":"Nat Med"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1086\/428480","article-title":"Polymorphisms in the tyrosine kinase 2 and interferon regulatory factor 5 genes are associated with systemic lupus erythematosus","volume":"76","author":"S Sigurdsson","year":"2005","journal-title":"Am J Hum Genet"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/ng1782","article-title":"A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus","volume":"38","author":"RR Graham","year":"2006","journal-title":"Nat Genet"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"6758","DOI":"10.1073\/pnas.0701266104","article-title":"Three functional variants of IFN regulatory factor 5 (IRF5) define risk and protective haplotypes for human lupus","volume":"104","author":"RR Graham","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/nrg2571","article-title":"Genetic susceptibility to SLE: new insights from fine mapping and genome-wide association studies","volume":"10","author":"IT Harley","year":"2009","journal-title":"Nat Rev Genet"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1093\/hmg\/ddl469","article-title":"Association of IRF5 in UK SLE families identifies a variant involved in polyadenylation","volume":"16","author":"DS Graham","year":"2007","journal-title":"Hum Mol Genet"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/sj.gene.6364407","article-title":"Opposed independent effects and epistasis in the complex association of IRF5 to SLE","volume":"8","author":"I Ferreiro-Neira","year":"2007","journal-title":"Genes Immun"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1002\/art.27223","article-title":"Genetic variants and disease-associated factors contribute to enhanced interferon regulatory factor 5 expression in blood cells of patients with systemic lupus erythematosus","volume":"62","author":"D Feng","year":"2010","journal-title":"Arthritis Rheum"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1002\/art.23613","article-title":"Association of the IRF5 risk haplotype with high serum interferon-alpha activity in systemic lupus erythematosus patients","volume":"58","author":"TB Niewold","year":"2008","journal-title":"Arthritis Rheum"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1093\/hmg\/ddm359","article-title":"Comprehensive evaluation of the genetic variants of interferon regulatory factor 5 (IRF5) reveals a novel 5 bp length polymorphism as strong risk factor for systemic lupus erythematosus","volume":"17","author":"S Sigurdsson","year":"2008","journal-title":"Hum Mol Genet"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"5348","DOI":"10.4049\/jimmunol.1103319","article-title":"IRF5 risk polymorphisms contribute to interindividual variance in pattern recognition receptor-mediated cytokine secretion in human monocyte-derived cells","volume":"188","author":"M Hedl","year":"2012","journal-title":"J Immunol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/nature03308","article-title":"Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors","volume":"434","author":"A Takaoka","year":"2005","journal-title":"Nature"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"6876","DOI":"10.4049\/jimmunol.178.11.6876","article-title":"Murine dendritic cell type I IFN production induced by human IgG-RNA immune complexes is IFN regulatory factor (IRF)5 and IRF7 dependent and is required for IL-6 production","volume":"178","author":"K Yasuda","year":"2007","journal-title":"J Immunol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"10154","DOI":"10.1073\/pnas.1005599107","article-title":"Contribution of IRF5 in B cells to the development of murine SLE-like disease through its transcriptional control of the IgG2a locus","volume":"107","author":"DA Savitsky","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"17005","DOI":"10.1074\/jbc.M412584200","article-title":"The interferon regulatory factor, IRF5, is a central mediator of toll-like receptor 7 signaling","volume":"280","author":"A Schoenemeyer","year":"2005","journal-title":"J Biol Chem"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"14295","DOI":"10.1074\/jbc.M800501200","article-title":"Functional characterization of murine interferon regulatory factor 5 (IRF-5) and its role in the innate antiviral response","volume":"283","author":"A Paun","year":"2008","journal-title":"J Biol Chem"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"3402","DOI":"10.1073\/pnas.0611559104","article-title":"Role of IFN regulatory factor 5 transcription factor in antiviral immunity and tumor suppression","volume":"104","author":"H Yanai","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1093\/intimm\/dxs114","article-title":"Phenotype and function of B cells and dendritic cells from interferon regulatory factor 5-deficient mice with and without a mutation in DOCK2","volume":"25","author":"K Yasuda","year":"2013","journal-title":"Int Immunol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1073\/pnas.0712295105","article-title":"A cell-type-specific requirement for IFN regulatory factor 5 (IRF5) in Fas-induced apoptosis","volume":"105","author":"A Couzinet","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1074\/jbc.M804744200","article-title":"IRF-5 is a mediator of the death receptor-induced apoptotic signaling pathway","volume":"284","author":"G Hu","year":"2009","journal-title":"J Biol Chem"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"796","DOI":"10.4049\/jimmunol.0901748","article-title":"IFN regulatory factor 5 is required for disease development in the FcgammaRIIB\u2212\/\u2212Yaa and FcgammaRIIB\u2212\/\u2212 mouse models of systemic lupus erythematosus","volume":"184","author":"C Richez","year":"2010","journal-title":"J Immunol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1002\/art.30183","article-title":"Interferon regulatory factor 5 is critical for the development of lupus in MRL\/lpr mice","volume":"63","author":"Y Tada","year":"2011","journal-title":"Arthritis Rheum"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1002\/eji.201141642","article-title":"Irf5-deficient mice are protected from pristane-induced lupus via increased Th2 cytokines and altered IgG class switching","volume":"42","author":"D Feng","year":"2012","journal-title":"Eur J Immunol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"4113","DOI":"10.4049\/jimmunol.1103113","article-title":"Pleiotropic IFN-dependent and -independent effects of IRF5 on the pathogenesis of experimental lupus","volume":"188","author":"Y Xu","year":"2012","journal-title":"J Immunol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"E898","DOI":"10.1073\/pnas.1118155109","article-title":"Spontaneous mutation of the Dock2 gene in Irf5\u2212\/\u2212 mice complicates interpretation of type I interferon production and antibody responses","volume":"109","author":"WE Purtha","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1038\/35090591","article-title":"Haematopoietic cell-specific CDM family protein DOCK2 is essential for lymphocyte migration","volume":"412","author":"Y Fukui","year":"2001","journal-title":"Nature"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1126\/science.1170179","article-title":"Sequential regulation of DOCK2 dynamics by two phospholipids during neutrophil chemotaxis","volume":"324","author":"A Nishikimi","year":"2009","journal-title":"Science"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1038\/ni1506","article-title":"T helper type 2 differentiation and intracellular trafficking of the interleukin 4 receptor-alpha subunit controlled by the Rac activator Dock2","volume":"8","author":"Y Tanaka","year":"2007","journal-title":"Nat Immunol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1084\/jem.20091776","article-title":"Selective control of type I IFN induction by the Rac activator DOCK2 during TLR-mediated plasmacytoid dendritic cell activation","volume":"207","author":"K Gotoh","year":"2010","journal-title":"J Exp Med"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.autrev.2012.08.018","article-title":"Lupus nephritis: a critical review","volume":"12","author":"AT Borchers","year":"2012","journal-title":"Autoimmun Rev"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/S0140-6736(11)61454-2","article-title":"Acute kidney injury","volume":"380","author":"R Bellomo","year":"2012","journal-title":"Lancet"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1084\/jem.148.5.1198","article-title":"Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains","volume":"148","author":"BS Andrews","year":"1978","journal-title":"J Exp Med"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3899\/jrheum.090194","article-title":"Interleukin 6 (IL-6) deficiency delays lupus nephritis in MRL-Faslpr mice: the IL-6 pathway as a new therapeutic target in treatment of autoimmune kidney disease in systemic lupus erythematosus","volume":"37","author":"H Cash","year":"2010","journal-title":"J Rheumatol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/nbt.2076","article-title":"The discovery and development of belimumab: the anti-BLyS-lupus connection","volume":"30","author":"W Stohl","year":"2012","journal-title":"Nat Biotechnol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1084\/jem.20062567","article-title":"BAFF and MyD88 signals promote a lupuslike disease independent of T cells","volume":"204","author":"JR Groom","year":"2007","journal-title":"J Exp Med"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.4049\/jimmunol.0802257","article-title":"Human B cell responses to TLR ligands are differentially modulated by myeloid and plasmacytoid dendritic cells","volume":"182","author":"I Douagi","year":"2009","journal-title":"J Immunol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.molimm.2012.06.013","article-title":"Murine BAFF expression is up-regulated by estrogen and interferons: implications for sex bias in the development of autoimmunity","volume":"53","author":"R Panchanathan","year":"2013","journal-title":"Mol Immunol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1038\/35010115","article-title":"TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease","volume":"404","author":"JA Gross","year":"2000","journal-title":"Nature"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"4664","DOI":"10.1073\/pnas.0911193107","article-title":"Critical role of IRF-5 in regulation of B-cell differentiation","volume":"107","author":"C Lien","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1084\/jem.20052438","article-title":"TLR9\/MyD88 signaling is required for class switching to pathogenic IgG2a and 2b autoantibodies in SLE","volume":"203","author":"M Ehlers","year":"2006","journal-title":"J Exp Med"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s00281-006-0037-0","article-title":"Molecular and cellular basis for pathogenicity of autoantibodies: lessons from murine monoclonal autoantibodies","volume":"28","author":"L Baudino","year":"2006","journal-title":"Springer Semin Immunopathol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"515","DOI":"10.4049\/jimmunol.147.2.515","article-title":"IgG3 production in MRL\/lpr mice is responsible for development of lupus nephritis","volume":"147","author":"S Takahashi","year":"1991","journal-title":"J Immunol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1745-6150-7-3","article-title":"IgG3 deficiency extends lifespan and attenuates progression of glomerulonephritis in MRL\/lpr mice","volume":"7","author":"NS Greenspan","year":"2012","journal-title":"Biol Direct"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.4049\/jimmunol.0902592","article-title":"TLR9 regulates TLR7- and MyD88-dependent autoantibody production and disease in a murine model of lupus","volume":"184","author":"KM Nickerson","year":"2010","journal-title":"J Immunol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1146\/annurev-immunol-020711-075032","article-title":"Germinal centers","volume":"30","author":"GD Victora","year":"2012","journal-title":"Annu Rev Immunol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.coi.2014.03.001","article-title":"The imperfect control of self-reactive germinal center B cells","volume":"28C","author":"R Brink","year":"2014","journal-title":"Curr Opin Immunol"},{"key":"ref47","article-title":"Distinct Regulation of Murine Lupus Susceptibility Genes by the IRF5\/Blimp-1 Axis","author":"R Panchanathan","year":"2011","journal-title":"J Immunol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/nri1572","article-title":"Regulation of plasma-cell development","volume":"5","author":"M Shapiro-Shelef","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/ni.1990","article-title":"IRF5 promotes inflammatory macrophage polarization and T(H)1-T(H)17 responses","volume":"12","author":"T Krausgruber","year":"2011","journal-title":"Nat Immunol"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1002\/eji.201242792","article-title":"IRF-5 and NF-kappaB p50 co-regulate IFN-beta and IL-6 expression in TLR9-stimulated human plasmacytoid dendritic cells","volume":"43","author":"F Steinhagen","year":"2013","journal-title":"Eur J Immunol"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"21078","DOI":"10.1074\/jbc.M500543200","article-title":"Two discrete promoters regulate the alternatively spliced human interferon regulatory factor-5 isoforms. Multiple isoforms with distinct cell type-specific expression, localization, regulation, and function","volume":"280","author":"ME Mancl","year":"2005","journal-title":"J Biol Chem"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.coi.2012.07.008","article-title":"The genetics of type I interferon in systemic lupus erythematosus","volume":"24","author":"PG Bronson","year":"2012","journal-title":"Curr Opin Immunol"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1084\/jem.20032000","article-title":"TACI and BAFF-R mediate isotype switching in B cells","volume":"201","author":"E Castigli","year":"2005","journal-title":"J Exp Med"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0103478","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,31]],"date-time":"2024-05-31T17:38:54Z","timestamp":1717177134000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0103478"}},"subtitle":[],"editor":[{"given":"Frederic","family":"Rieux-Laucat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,7,30]]},"references-count":53,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2014,7,30]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0103478","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7,30]]}}}